Picture of Sundrug Co logo

9989 Sundrug Co Share Price

0.000.00%
jp flag iconLast trade - 00:00
Consumer DefensivesBalancedLarge CapHigh Flyer

Momentum

Relative Strength (%)
1m+2.71%
3m-11.55%
6m-5.68%
1yr-8.1%
Volume Change (%)
10d/3m-8.55%
Price vs... (%)
52w High-0.65%
50d MA+6.04%
200d MA+12.35%

Growth & Value

12m Forecast RollingIndustryMarket
PE Ratio (f)18.54
PEG Ratio (f)2.63
EPS Growth (f)7.58%
Dividend Yield (f)2.6%
Valuation (ttm)IndustryMarket
Price to Book Value2.31
Price to Tang. Book2.4
Price to Free Cashflow177.16
Price to Sales0.77
EV to EBITDA9.14

Shareholder Activity

TypeBuy / Hold / Sell
Institutions
Directors
Community

Guru Screens

Quality

NameIndustryMarket
Return on Capital15.72%
Return on Equity11.77%
Operating Margin5.5%

Financial Summary

Year End 31st MarUnit201920202021202220232024E2025ECAGR / Avg
Total Revenue¥m588,069617,769634,310648,734690,462752,246809,7294.12%
Operating Profitm
Net Profitm
EPS Reported
Diluted Normalised EPS
EPS Growth%-2.07+4+2.45-8.23+8.77+10.04+7.54n/a
PE Ratiox
PEG
Profitability
Operating Margin%
ROA%
ROCE%
ROE%
Cashflow
Op. Cashflow ps
Capex ps
Free Cashflow ps
Dividends
Dividend ps
Dividend Growth%
Dividend Yield%
Dividend Coverx
Balance Sheet
Cash etcm
Working Capitalm
NFAm
Net Debtm
Book Valuem
Diluted Weighted Average Sharesm
Book Value ps

Health Trend(F-Score)

12345678910

Bankruptcy Score(Z-Score)

Distress
Cautious
Safe

Earnings Manipulation Risk(M-Score)

Other Ratios

Leverage (ttm)Total- Intang+ Pension
Gross Gearing
Net Gearing
Cash / Assets

Recent History

Latest interim period vs. prior periodIndustryMarket
Sales Growth
EPS Growth
3yr Compound Annual Growth RateIndustryMarket
Sales CAGR
EPS CAGR
DPS CAGR

Graphical History

Revenue
Blurred out image of Revenue chart
Net Income
Blurred out image of Net Income chart
Normalised EPS
Blurred out image of Normalised EPS chart
PE Ratio Range
Blurred out image of PE Ratio Range chart
Dividend Yield Range
Blurred out image of Dividend Yield Range chart

Analyst Forecasts

Price target
( price)
31st Mar 202431st Mar 2025
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change

Analyst Consensus

Strong SellSellHoldBuyStrong Buy

EPS 2024 / 2025

Blurred out image of Sundrug Co EPS forecast chart

Profile Summary

SUNDRUG CO., LTD. is a Japan-based company operating in two business segments. The Drug Store segment is primarily engaged in the sale of pharmaceutical products, cosmetic products and sundry goods, among others. The Discount Store segment is primarily engaged in the sale of foodstuffs, household sundry goods, among others.

Directors

Last Annual
March 31st, 2023
Last Interim
December 31st, 2023
Incorporated
April 28th, 1965
Public Since
September 17th, 1997
No. of Shareholders
19,253
No. of Employees
6,371
Sector
Food & Drug Retailing
Industry
Consumer Defensives
Exchange
jp flag iconTokyo Stock Exchange
Shares in Issue
116,951,685

9989 Share Price Performance

Upcoming Events for 9989

Dividend For 9989.T - 57.0000 JPY

Full Year 2024 Sundrug Co Ltd Earnings Release

Sundrug Co Ltd Annual Shareholders Meeting

Q1 2025 Sundrug Co Ltd Earnings Release

Similar to 9989

Picture of Aeon Co logo

Aeon Co

jp flag iconTokyo Stock Exchange

Picture of Ain Holdings logo

Ain Holdings

jp flag iconTokyo Stock Exchange

Picture of Albis Co logo

Albis Co

jp flag iconTokyo Stock Exchange

Picture of Aoki Super Co logo

Aoki Super Co

jp flag iconTokyo Stock Exchange

Picture of Arcs Co logo

Arcs Co

jp flag iconTokyo Stock Exchange

FAQ